ProSciento and OWL Metabolomics Team Up to Accelerate NAFLD/NASH Trial Recruitment
News
ProSciento and OWL Metabolomics announced an exclusive, long-term partnership to identify eligible participants for clinical trial enrollment to evaluate therapeutic candidates for non-alcoholic ... Read more